Catheter Cap Market Size, Share, & Trends Analysis | Global | 2026-2032

Global Catheter Cap Market Report to 2032

The global catheter cap market was valued at $349 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching over $433 million by 2032.

This report covers the global market for catheter caps, including single-use disinfection devices designed to cover needleless connectors and open catheter ports between accesses.

The analysis includes unit sales, average selling prices (ASPs), market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by increased uptake with long-term catheters, demographic trends, and rising catheter utilization. However, the total cost of caps over a catheter's lifetime and the increased use of antimicrobial PICCs and CVCs continue to limit stronger expansion.

Market Overview

The global catheter cap market includes disinfection caps used to reduce microbial colonization at catheter hubs, needleless connectors, and open catheter ports.

Catheter caps are single-use products that typically contain an antiseptic agent. When applied to the catheter hub or connector, the antiseptic is released upon contact with residual fluid, providing passive disinfection between line manipulations.

These devices are used as adjunct infection-prevention products across vascular access care. They are especially relevant for long-term catheters such as PICCs and CVCs, where catheter dwell time is longer and infection prevention is a major concern.

Underlying catheter utilization trends continue to support long-term growth. Aging populations and rising prevalence of chronic disease are increasing hospitalization rates and reliance on vascular access devices. Since most hospitalized patients receive at least one catheter during their stay, growth in catheter placements directly supports demand for catheter caps.

Market Drivers

Increased Uptake of Long-Term Catheters

Increased uptake of catheter caps with long-term catheters is a major driver of the market. Central line catheters such as PICCs and CVCs have a significantly higher infection risk because of their longer dwell times.

Reducing infection rates is a primary concern for healthcare facilities. Treating catheter-related bloodstream infections can be costly, time consuming, and harmful to patient outcomes.

Some catheter cap products have been shown to reduce catheter-related bloodstream infections by 40% to 70%. This clinical value supports adoption, especially in higher-risk catheter categories.

It is currently estimated that only approximately 30% of all central lines use catheter caps. This leaves a significant opportunity for growth as more hospitals adopt disinfection caps as part of central line management protocols.

Demographic Factors

Demographic factors also support the catheter cap market. The world population is increasing at approximately 0.9% per year, while the elderly population is increasing at around 1.8% per year.

This demographic shift is contributing to an increased number of hospitalizations. Older patients are more likely to require infusion therapy, chronic disease management, central venous access, dialysis access, or other forms of catheter-based care.

The vast majority of hospitalized patients receive some type of catheter. As catheter use rises, demand for adjunct infection-prevention products, including catheter caps, is expected to grow over the forecast period.

Infection Prevention and Passive Disinfection

Infection prevention remains central to catheter cap adoption. Catheter hubs and needleless connectors are frequent access points, and repeated line manipulation increases the risk of microbial contamination.

Catheter caps provide continuous passive disinfection between accesses. This means the device helps protect the access point even when staff are not actively cleaning the connector.

This passive workflow advantage is important in busy hospital environments. Caps can help standardize disinfection practices, reduce reliance on manual compliance alone, and support infection-prevention protocols across both acute and long-term care settings.

Market Limiters

Relatively High Cost of Caps Over Catheter Lifetime

The cost of catheter caps over the lifetime of the catheter is a major market limiter. Individual catheter caps are relatively inexpensive, and for higher-priced catheters such as PICCs and CVCs, many healthcare providers view the cost as justifiable.

However, for lower-priced devices such as PIVCs, the total cost of caps used over the catheter's lifetime can approach the cost of the catheter itself.

In this context, using disinfection caps for PIVCs can effectively double the cost of the device. Some facilities may not view this as a justified increase, especially when PIVCs are used in very high volumes.

Because PIVCs are the most commonly inserted catheters, any barrier to penetration in that space is expected to limit growth of the overall catheter cap market.

Increased Usage of Antimicrobial PICCs and CVCs

The increasing use of antimicrobial PICCs and CVCs is another important limiter. Central lines are increasingly made with advanced materials designed to reduce bloodstream infections.

These antimicrobial catheters serve a similar purpose to catheter caps by reducing infection risk associated with catheter use. As these advanced devices continue to penetrate the market, some healthcare facilities may question whether additional products are necessary.

If hospitals believe antimicrobial catheters already provide sufficient infection protection, they may be less willing to purchase catheter caps for every access point. This may limit cap adoption, especially in facilities trying to control vascular access costs.

Cost Sensitivity in High-Volume Catheter Use

Catheter caps are used repeatedly because they are replaced each time the port is accessed. This creates strong recurring demand, but it also raises cost sensitivity.

In high-volume settings, multiple caps may be used per catheter each day. While this supports unit sales, it also increases the total cost of using caps as a standard protocol.

Facilities must weigh the cost of repeated cap use against the potential cost savings from preventing infections. Where infection risk is viewed as lower or budgets are constrained, adoption may be slower.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by competitive share analysis and forecast assumptions.
• Device scope: The report covers catheter caps used to disinfect needleless connectors and open catheter ports between accesses. These devices are used across vascular access settings as adjunct infection-prevention products.

Markets Covered and Segmentation

Catheter Cap Market

The report covers the global catheter cap market as a dedicated vascular access accessory segment.

Catheter caps are single-use disinfection devices designed to cover needleless connectors and open catheter ports between accesses. They typically contain an antiseptic agent that is released upon contact with residual fluid in the catheter hub.

These caps provide continuous passive disinfection and help reduce microbial colonization of the access point between line manipulations.

The market is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.

Demand is evaluated based on catheter utilization, central line adoption, infection-prevention protocols, PIVC penetration, long-term catheter use, demographic trends, and competitive positioning.

This structure helps manufacturers, investors, and strategy teams understand how catheter cap adoption is shaped by infection-prevention priorities, catheter placement volumes, product cost, and the expansion of advanced antimicrobial catheter technologies.

Competitive Analysis

In April 2024, 3M completed the planned spin-off of its health care business, formally launching Solventum Corp. as an independent company. In 2025, Solventum held the leading position in the catheter cap market with its Curos(TM) line of disinfection products.

Curos(TM) caps are designed to disinfect catheter ports and are suitable for needleless connectors and Luers. They contain an isopropyl alcohol solution that is proven to disinfect open catheter ports within a minute.

The products provide protection for up to 7 days and are replaced each time the port is accessed. Since catheter ports may be accessed multiple times per day, this results in repeated cap usage and supports recurring unit sales.

Solventum highlights the cost-saving potential of Curos(TM) caps compared with treating infections. While study results vary, many estimates suggest savings of more than $30,000 associated with Curos(TM) cap usage.

Solventum is also a leader in the catheter securement market, supported by products such as Tegaderm(TM) dressings and Curos(TM) caps. This broader vascular access infection-prevention portfolio strengthens the company's market position.

ICU Medical emerged as the second-leading player in the catheter cap market, particularly in dialysis caps, following its acquisition of Pursuit Vascular in 2019. Pursuit Vascular's ClearGuard(R) HD caps use chlorhexidine for disinfection and have been associated with around a 70% reduction in catheter-related bloodstream infections.

Technology and Practice Trends

Passive Disinfection

Passive disinfection is a key trend in the catheter cap market. Caps remain on the connector or catheter port between accesses, helping maintain disinfection without requiring repeated manual scrubbing alone.

This supports more consistent infection-prevention workflows.

Isopropyl Alcohol Caps

Isopropyl alcohol-based caps remain important in the market. Solventum's Curos(TM) line uses isopropyl alcohol solution to disinfect open catheter ports and needleless connectors.

These products are widely used as part of vascular access infection-prevention protocols.

Chlorhexidine-Based Dialysis Caps

Chlorhexidine-based caps are important in dialysis applications. ICU Medical's ClearGuard(R) HD caps use chlorhexidine for disinfection and target catheter-related bloodstream infection reduction in hemodialysis access.

This supports ICU Medical's position in dialysis-related catheter cap use.

Central Line Infection Prevention

Central lines such as PICCs and CVCs remain a major focus for catheter cap use because of their longer dwell times and higher infection risk.

This creates a major growth opportunity because only around 30% of central lines are estimated to use catheter caps.

PIVC Cost Challenge

PIVC adoption remains more difficult because the total cost of cap use can approach or exceed the cost of the catheter itself.

For broader PIVC adoption, companies may need stronger economic evidence or lower-cost cap options.

Competition from Antimicrobial Catheters

Antimicrobial PICCs and CVCs are increasingly used to reduce bloodstream infection risk. These products may reduce the perceived need for separate catheter caps.

This trend may limit cap adoption in some facilities.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global catheter cap market today, and how much is it expected to grow through 2032?
• How are unit sales, ASPs, and market values changing over time?
• How do catheter caps support passive disinfection of needleless connectors and open catheter ports?
• How does the rising use of long-term catheters affect cap demand?
• Why do PICCs and CVCs represent a major growth opportunity for catheter caps?
• How do catheter caps reduce catheter-related bloodstream infection risk?
• Why does repeated cap use create a cost barrier for PIVC adoption?
• How are antimicrobial PICCs and CVCs affecting catheter cap demand?
• Which companies lead the global catheter cap market?
• How are Solventum and ICU Medical positioned across standard catheter caps, dialysis caps, and vascular access infection-prevention workflows?

The Global Catheter Cap Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand passive disinfection adoption, and support commercial planning in the global catheter cap market.